Skip to content
10-K

Annual Report

TRIUS THERAPEUTICS INC

0001193125-13-105369

← back to feed
Filed
Mar 13, 2013 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 1, 2013 47.85M sh
Shares Diluted FY 2012 · Dec 31, 2012 39.62M sh
Shares Diluted FY 2012 · Dec 31, 2012 38.08M sh
Shares Diluted FY 2012 · Sep 30, 2012 38.78M sh
Shares Diluted FY 2012 · Jun 30, 2012 38.18M sh
Shares Diluted FY 2012 · Mar 31, 2012 35.2M sh
Shares Diluted FY 2012 · Dec 31, 2011 28.6M sh
Shares Diluted FY 2012 · Dec 31, 2011 26.52M sh
Shares Diluted FY 2012 · Sep 30, 2011 29.48M sh
Shares Diluted FY 2012 · Jun 30, 2011 25.26M sh
Shares Diluted FY 2012 · Mar 31, 2011 23.61M sh
Capex FY 2012 · Dec 31, 2012 $613K
Capex FY 2012 · Dec 31, 2011 $833K
Capex FY 2012 · Dec 31, 2010 $593K
Operating Cash Flow FY 2012 · Dec 31, 2012 −$49.5M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$13.24M
Operating Cash Flow FY 2012 · Dec 31, 2010 −$18.72M
Cash And Equivalents FY 2012 · Dec 31, 2012 $16.37M
Cash And Equivalents FY 2012 · Dec 31, 2011 $11.38M
Cash And Equivalents FY 2012 · Dec 31, 2010 $14.52M
Cash And Equivalents FY 2012 · Dec 31, 2009 $18.26M
Stockholders Equity FY 2012 · Dec 31, 2012 $56.79M
Stockholders Equity FY 2012 · Dec 31, 2011 $49.89M
Stockholders Equity FY 2012 · Dec 31, 2010 $45.45M
Stockholders Equity FY 2012 · Dec 31, 2009 −$51.5M
Current Liabilities FY 2012 · Dec 31, 2012 $18.49M
Current Liabilities FY 2012 · Dec 31, 2011 $18.23M
Current Assets FY 2012 · Dec 31, 2012 $73.98M
Current Assets FY 2012 · Dec 31, 2011 $66.69M
Total Assets FY 2012 · Dec 31, 2012 $75.27M
Total Assets FY 2012 · Dec 31, 2011 $68.13M
Eps Diluted FY 2012 · Dec 31, 2012 −$0.36
Eps Diluted FY 2012 · Dec 31, 2012 −$1.42
Eps Diluted FY 2012 · Sep 30, 2012 −$0.46
Eps Diluted FY 2012 · Jun 30, 2012 −$0.37
Eps Diluted FY 2012 · Mar 31, 2012 −$0.22
Eps Diluted FY 2012 · Dec 31, 2011 −$0.44
Eps Diluted FY 2012 · Dec 31, 2011 −$0.69
Eps Diluted FY 2012 · Sep 30, 2011 $0.49
Eps Diluted FY 2012 · Jun 30, 2011 −$0.40
Eps Diluted FY 2012 · Mar 31, 2011 −$0.43
Eps Basic FY 2012 · Dec 31, 2012 −$0.36
Eps Basic FY 2012 · Dec 31, 2012 −$1.42
Eps Basic FY 2012 · Sep 30, 2012 −$0.46
Eps Basic FY 2012 · Jun 30, 2012 −$0.37
Eps Basic FY 2012 · Mar 31, 2012 −$0.22
Eps Basic FY 2012 · Dec 31, 2011 −$0.44
Eps Basic FY 2012 · Dec 31, 2011 −$0.69
Eps Basic FY 2012 · Sep 30, 2011 $0.50
Eps Basic FY 2012 · Jun 30, 2011 −$0.40
Eps Basic FY 2012 · Mar 31, 2011 −$0.43
Eps Basic FY 2012 · Dec 31, 2010 −$2.36
Sga Expense FY 2012 · Dec 31, 2012 $15.4M
Sga Expense FY 2012 · Dec 31, 2011 $11.34M
Sga Expense FY 2012 · Dec 31, 2010 $5.41M
Rd Expense FY 2012 · Dec 31, 2012 $69.02M
Rd Expense FY 2012 · Dec 31, 2011 $49.5M
Rd Expense FY 2012 · Dec 31, 2010 $23.32M
Net Income FY 2012 · Dec 31, 2012 −$53.93M
Net Income FY 2012 · Dec 31, 2011 −$18.25M
Net Income FY 2012 · Dec 31, 2010 −$23.86M
Operating Income FY 2012 · Dec 31, 2012 −$57.23M
Operating Income FY 2012 · Dec 31, 2011 −$19.83M
Operating Income FY 2012 · Dec 31, 2010 −$20.69M
Revenue FY 2012 · Dec 31, 2012 $5.16M
Revenue FY 2012 · Dec 31, 2012 $27.19M
Revenue FY 2012 · Sep 30, 2012 $5.97M
Revenue FY 2012 · Jun 30, 2012 $6.22M
Revenue FY 2012 · Mar 31, 2012 $9.83M
Revenue FY 2012 · Dec 31, 2011 $5M
Revenue FY 2012 · Dec 31, 2011 $41.01M
Revenue FY 2012 · Sep 30, 2011 $30.44M
Revenue FY 2012 · Jun 30, 2011 $2.86M
Revenue FY 2012 · Mar 31, 2011 $2.72M
Revenue FY 2012 · Dec 31, 2010 $8.03M
Stock Repurchased FY 2012 · Dec 31, 2010 $1K